These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 19657925)
21. Management of reflux disease in clinical praxis in hungary. Hritz I; Prónai L; Szalay F; Tulassay Z Z Gastroenterol; 2005 Jun; 43(6):575-80. PubMed ID: 15986286 [TBL] [Abstract][Full Text] [Related]
22. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea. Suh HS; Lee D; Kim SY; Chee DH; Kang HY Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104 [TBL] [Abstract][Full Text] [Related]
23. Self-reported influence of television-based direct-to-consumer advertising on patient seasonal allergy and asthma medication use: An internet survey. Khanfar NM; Clauson KA; Polen HH; Shields KM Curr Ther Res Clin Exp; 2008 Apr; 69(2):130-41. PubMed ID: 24692792 [TBL] [Abstract][Full Text] [Related]
25. Dosing of proton pump inhibitors is suboptimal among otolaryngologists treating reflux-induced upper-respiratory disease. Humayun F; Hoff PT; Robinson EA; Gunaratnam NT Otolaryngol Head Neck Surg; 2007 Dec; 137(6):936-941. PubMed ID: 18036424 [TBL] [Abstract][Full Text] [Related]
26. Marked increase in proton pump inhibitors use in Australia. Hollingworth S; Duncan EL; Martin JH Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646 [TBL] [Abstract][Full Text] [Related]
27. The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use. Targownik LE; Metge C; Roos L; Leung S Am J Gastroenterol; 2007 May; 102(5):942-50. PubMed ID: 17313495 [TBL] [Abstract][Full Text] [Related]
28. Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease. Diaz DM; Winter HS; Colletti RB; Ferry GD; Rudolph CD; Czinn SJ; Cochran W; Gold BD; J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):56-64. PubMed ID: 17592365 [TBL] [Abstract][Full Text] [Related]
29. Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study. Jones R; Armstrong D; Malfertheiner P; Ducrotté P Curr Med Res Opin; 2006 Apr; 22(4):657-62. PubMed ID: 16684426 [TBL] [Abstract][Full Text] [Related]
30. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472 [TBL] [Abstract][Full Text] [Related]
31. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Bradford WD; Kleit AN; Nietert PJ; Ornstein S Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467 [TBL] [Abstract][Full Text] [Related]
32. Trust in online prescription drug information among internet users: the impact on information search behavior after exposure to direct-to-consumer advertising. Menon AM; Deshpande AD; Perri M; Zinkhan GM Health Mark Q; 2002; 20(1):17-35. PubMed ID: 12749596 [TBL] [Abstract][Full Text] [Related]
33. What makes individuals with gastroesophageal reflux disease dissatisfied with their treatment? Bytzer P Clin Gastroenterol Hepatol; 2009 Aug; 7(8):816-22. PubMed ID: 19286478 [TBL] [Abstract][Full Text] [Related]
34. Impact of celebrity pitch in direct-to-consumer advertising of prescription drugs. Bhutada NS; Menon AM; Deshpande AD; Perri M Health Mark Q; 2012; 29(1):35-48. PubMed ID: 22416924 [TBL] [Abstract][Full Text] [Related]
35. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion. Danzig J; Navarro R; Inami D; Morreale A; Tokayer A; Wong W; Compton J; Page RN; Sweet FB Manag Care Interface; 2001; Suppl B():13-20; discussion 24-7, 31-3. PubMed ID: 11569294 [TBL] [Abstract][Full Text] [Related]
36. When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study. Fourrier-Réglat A; Lacoin L; Pariente A; Lassalle R; Robinson P; Droz-Perroteau C; Bégaud B; Blin P; Moore ND Clin Pharmacol Ther; 2010 Nov; 88(5):668-75. PubMed ID: 20861835 [TBL] [Abstract][Full Text] [Related]
37. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings. Sneed RC; May WL; Stencel C Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092 [TBL] [Abstract][Full Text] [Related]
38. Factors affecting osteoarthritis patients' self-reported goal-directed drug information-seeking behaviors after exposure to direct-to-consumer advertising from physicians and the internet. Liu Y; Farris KB; Doucette WR Hosp Pract (1995); 2011 Oct; 39(4):76-81. PubMed ID: 22056826 [TBL] [Abstract][Full Text] [Related]
39. Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: application of the availability heuristic. An S Health Commun; 2008 Nov; 23(6):499-505. PubMed ID: 19089697 [TBL] [Abstract][Full Text] [Related]
40. Diagnosis and treatment of gastroesophageal reflux disease in Ohio Medicaid patients: practice patterns and temporal trends. Cooper GS; Mourad WA; Koroukian SM Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):21-7. PubMed ID: 14971119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]